Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125146972 | 12514697 | 2 | F | 201312 | 20160810 | 20160630 | 20160912 | PER | US-JNJFOC-20160524785 | JANSSEN | 64.41 | YR | A | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125146972 | 12514697 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | 10 | MG | TABLET | |||||
125146972 | 12514697 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | TABLET | |||||||
125146972 | 12514697 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | ||||
125146972 | 12514697 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | TABLET | |||||||
125146972 | 12514697 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | 10 | MG | TABLET | |||||
125146972 | 12514697 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | ||||
125146972 | 12514697 | 7 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | ||||
125146972 | 12514697 | 8 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 0 | 10 | MG | TABLET | |||||
125146972 | 12514697 | 9 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | N | UNKNOWN | 202439 | TABLET | |||||||
125146972 | 12514697 | 10 | SS | IBUPROFEN. | IBUPROFEN | 1 | Unknown | U | U | 19012 | UNSPECIFIED | ||||||||
125146972 | 12514697 | 11 | SS | IBUPROFEN. | IBUPROFEN | 1 | Unknown | U | U | 19012 | UNSPECIFIED | ||||||||
125146972 | 12514697 | 12 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | N | 0 | 81 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125146972 | 12514697 | 1 | Atrial fibrillation |
125146972 | 12514697 | 2 | Atrial fibrillation |
125146972 | 12514697 | 3 | Atrial fibrillation |
125146972 | 12514697 | 4 | Thrombosis prophylaxis |
125146972 | 12514697 | 5 | Thrombosis prophylaxis |
125146972 | 12514697 | 6 | Thrombosis prophylaxis |
125146972 | 12514697 | 7 | Cerebrovascular accident prophylaxis |
125146972 | 12514697 | 8 | Cerebrovascular accident prophylaxis |
125146972 | 12514697 | 9 | Cerebrovascular accident prophylaxis |
125146972 | 12514697 | 11 | Gout |
125146972 | 12514697 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125146972 | 12514697 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125146972 | 12514697 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125146972 | 12514697 | 2 | 201501 | 0 | ||
125146972 | 12514697 | 3 | 20130501 | 20140122 | 0 | |
125146972 | 12514697 | 4 | 201501 | 0 | ||
125146972 | 12514697 | 6 | 20130501 | 20140122 | 0 | |
125146972 | 12514697 | 7 | 20130501 | 20140122 | 0 | |
125146972 | 12514697 | 9 | 201501 | 0 |